DB
RGNX icon

Dmitry Balyasny’s Regenxbio RGNX Stock Holding History

Dmitry Balyasny’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$887K Buy
74,047
+62,391
+535% +$518K ﹤0.01% 2278
2026
Q1 		$97.7K Buy
11,656
+1,231
+12% +$12.9K ﹤0.01% 2758
2025
Q4 		$150K Buy
+10,425
New +$130K ﹤0.01% 2922
2025
Q3 		– Sell
-797,100
Closed -$6.54M – 3386
2025
Q2 		$6.54M Sell
797,100
-601,397
-43% -$5.03M 0.01% 1159
2025
Q1 		$10M Buy
1,398,497
+211,395
+18% +$1.57M 0.02% 912
2024
Q4 		$9.18M Buy
1,187,102
+66,993
+6% +$629K 0.01% 998
2024
Q3 		$11.7M Buy
1,120,109
+313,394
+39% +$3.82M 0.02% 863
2024
Q2 		$9.44M Buy
806,715
+379,760
+89% +$5.91M 0.02% 913
2024
Q1 		$9M Buy
426,955
+230,882
+118% +$4.11M 0.02% 978
2023
Q4 		$3.52M Sell
196,073
-591,550
-75% -$10.4M 0.01% 1255
2023
Q3 		$13M Buy
787,623
+238,677
+43% +$4.33M 0.03% 745
2023
Q2 		$11M Buy
548,946
+172,646
+46% +$3.33M 0.02% 733
2023
Q1 		$7.12M Buy
376,300
+375,427
+43,004% +$8.31M 0.02% 929
2022
Q4 		$19.8K Buy
+873
New +$19.7K ﹤0.01% 2483
2019
Q3 		– Sell
-152,521
Closed -$7.83M – 1512
2019
Q2 		$7.83M Buy
152,521
+144,504
+1,802% +$7.21M 0.05% 474
2019
Q1 		$459K Buy
+8,017
New +$397K ﹤0.01% 1227
2018
Q4 		– Sell
-65,583
Closed -$3.85M – 1696
2018
Q3 		$4.95M Sell
65,583
-23,937
-27% -$1.72M 0.02% 701
2018
Q2 		$6.42M Sell
89,520
-53,536
-37% -$2.56M 0.03% 611
2018
Q1 		$4.27M Buy
+143,056
New +$4.16M 0.02% 758

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Dmitry Balyasny's RGNX Position: Q2 2026 in Review

Dmitry Balyasny increased its Regenxbio (RGNX) stake by 535% in Q2 2026, buying an estimated $518K and bringing the position to 74,047 shares worth $887K. The position accounts for ﹤0.01% of the portfolio, ranked #2278.

Dmitry Balyasny first reported a position in RGNX in Q1 2018 and has held it in 19 quarters since. The position peaked at $13M in Q3 2023. 164 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Dmitry Balyasny held 74,047 shares of Regenxbio worth $887K as of Q2 2026.
  • Dmitry Balyasny bought 62,391 Regenxbio shares in Q2 2026, an estimated $518K.
  • Regenxbio made up ﹤0.01% of Dmitry Balyasny's portfolio in Q2 2026, its #2278 holding.
  • Dmitry Balyasny first reported a position in Regenxbio in Q1 2018 and has held it in 19 quarters since.
  • Dmitry Balyasny's Regenxbio position peaked at $13M in Q3 2023.
  • 164 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.